Is short duration trastuzumab adequate adjuvant therapy for HER-2 overexpressing breast cancers?

Goyal, LovenishGupta, Sudeep2006-09-062009-06-032006-09-062009-06-032006-09-06Goyal L, Gupta S. Is short duration trastuzumab adequate adjuvant therapy for HER-2 overexpressing breast cancers? National Medical Journal of India. 2006 Sep-Oct; 19(5): 264-5http://imsear.searo.who.int/handle/123456789/118144engIs short duration trastuzumab adequate adjuvant therapy for HER-2 overexpressing breast cancers?Journal Article